Objective: To determine whether proton magnetic resonance spectroscopy (1H-MRS) could be a useful tool for detecting microscopic diffuse axonal injury to evaluate the functional status of patients with traumatic brain injury (TBI).
Design: A comparative study.
Setting: An inpatient rehabilitation unit in Korea.
Subjects: We examined eight adult patients who had severe TBI approximately five months before. Fourteen normal controls were employed for comparison.
Main measures: Image-guided localized in vivo 1H-MRS was performed in the parietal white matter and occipital grey matter regions in brain in which no definite abnormalities in MR imaging were found at the time of 1H-MRS examination. We evaluated functional status for all patients with the Functional Independence Measure (FIM) on the same day as the 1H-MRS examination and compared the results.
Results: In the parietal white matter, the [N-acetyl aspartate/creatine] ratios were significantly lower, and the [choline/creatine] and [myo-inositol/creatine] ratios were significantly higher than those of normal controls. Significant correlations of the [N-acetyl aspartate/creatine] and [myo-inositol/creatine] ratios in the parietal white matter with FIM scores were observed (p≤0.05).
Conclusions: A spectral feature of the decreased [N-acetyl aspartate/creatine] and increased [choline/creatine] and [myo-inositol/creatine] ratios in parietal white matter may be a marker for diffuse axonal injury in patients with TBI and has a significant correlation with the functional status of the patients. Localized 1H-MRS has the potential to be used for detecting diffuse axonal injury in vivo in TBI patients, which can be used to guide evaluation of the functional status of TBI patients receiving rehabilitation.
Get full access to this article
View all access options for this article.
References
1.
1 Adams JH, Graham DI, Murray LS, Scott G. Diffuse axonal injury due to nonmissile head injury in humans: an analysis of 45 cases. Ann Neurol1982; 12: 557-563.
3 Cecil KM, Hills EC, Sandel E et al. Proton magnetic resonance spectroscopy for detection of axonal injury in the splenium of the corpus callosum of brain-injured patients. J Neurosurg1998; 88: 795-801.
4.
4 Mittl RL, Grossman RI, Hiehle JF et al. Prevalence of MR evidence of diffuse axonal injury in patients with mild head injury and normal CT findings. Am J Neuroradiol1994; 15: 1583-1589.
5.
5 Cecil KM, Lenkinski RE, Meaney DF, McIntosh TK, Smith DH. High-field proton magnetic resonance spectroscopy of swine model for axonal injury. J Neurochem1998; 70: 2038-2044.
6.
6 Rango M, Spagnoli D, Tomei G et al. Central nervous system trans-synaptic effects of acute axonal injury: a 1H magnetic resonance spectroscopy study. Magn Reson Med1995; 33: 595-600.
7.
7 Smith DH, Meaney DF, Lenkinski RE et al. New magnetic resonance imaging techniques for the evaluation of traumatic brain injury. J Neurotrauma1995; 12: 573-577.
8.
8 Friedman SD, Brooks WM, Jung RE et al. Quantitative proton MRS predicts outcome after traumatic brain injury. Neurology1999; 52: 1384-1391.
9.
9 Friedman SD, Brooks WM, Jung RE, Hart BL, Yeo RA. Proton MR spectroscopic findings correspond to neuropsychological function in traumatic brain injury. Am J Neuroradiol1998; 19: 1879-1885.
10.
10 Vink R, Heath DL, McIntosh TK. Acute and prolonged alterations in brain free magnesium following fluid percussion-induced brain trauma in rats. J Neurochem1996; 66: 2477-2483.
11.
11 Vink R, McIntosh TK, Weiner MW, Faden AI. Effects of traumatic brain injury on cerebral high-energy phosphates and pH.: a 31P magnetic resonance spectroscopy study. J Cereb Blood Flow Metab1987; 7: 563-571.
12.
12 Chang L, Ernst T, Poland RE, Jenden DJ. In vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sci1996; 58: 2049-2056.
13.
13 Kreis R, Ernst T, Ross BD. Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med1993; 30: 424-437.
14.
14 Saunders DE, Howe FA, van den Boogaart A, Griffiths JR, Brown MM. Aging of the adult human brain: in vivo quantitation of metabolite content with proton magnetic resonance spectroscopy. J Magn Reson Imaging1999; 9: 711-716.
15.
15 Graham GD, Blamire AM, Rothman DL et al. Early temporal variation of cerebral metabolites after human stroke. Stroke1993; 24: 1891-1896.
17 Helpern JA, Linda V, Welch KMA et al. Acute elevation and recovery of intracellular [Mg2] following human focal cerebral ischemia. Neurology1993; 43: 1577-1581.
18.
18 Dodds TA, Martin DP, Stolov WC, Deyo RA. A validation of the functional independence measurement and its performance among rehabilitation inpatients. Arch Phys Med Rehabil1993; 74: 531-536.
19.
19 Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q1994; 10: 191-247.
20.
20 Lee JH, Arcinue E, Ross BD. Organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med1994; 331: 439-442.
21.
21 Chan YL, Yeung DKW, Leung SF, Cao G. Proton magnetic resonance spectroscopy of late delayed radiation-induced injury of the brain. J Magn Reson Imaging1999; 10: 130-137.
22.
22 Choe BY, Suh TS, Choi KH et al. Neuronal dysfunction in patients with closed head injury evaluated by in vivo 1H magnetic resonance spectroscopy. Invest Radiol1995; 30: 502-506.
